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Camptodactyly-Arthropathy-Coxa vara-Pericarditis (CACP) syndrome is a rare autosomal recessive disorder caused by mutations
in PRG4 gene that encodes for proteoglycan 4, a mucin-like glycoprotein that is the major lubricant for joints and tendon
surfaces. The molecular studies reported so far have described the identification of 15 mutations associated with this syndrome
and the majority of them were found in families of Arabian origin. Here we report the molecular investigation of the largest
European cohort that comprises 13 patients, and allowed the identification of 5 novel mutations and of the first case of
CACP syndrome resulting from uniparental disomy of chromosome 1.
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INTRODUCTION
Camptodactyly-Arthropathy-Coxa vara-Pericarditis (CACP) syndrome
is a rare genetic disorder characterized by autosomal recessive
inheritance (MIM 208250).
CACP patients have normal joints at birth, but with aging they
experience a noninflammatory hyperplasia of the synoviocytes, which
is responsible for the development of camptodactyly and arthropathy
that lead to premature joint contracture.1 Progressive coxa vara
deformity and pericarditis can also occur.2,3
The locus associated with this syndrome was identified on human
chromosome 1q25-q31 by homozygosity mapping,1 and the PRG4
gene was later identified as the causative gene.4 This gene is expressed
in several organs, including liver, lung, heart and highly in synovial
tissue. Among different transcripts derived from PRG4 gene by
alternative splicing,5 lubricin is a 1404 amino-acid glycoprotein
secreted by fibroblastic synoviocytes, chondrocytes in the superficial
zone of articular cartilage and by cell lining of tendon sheaths. It is the
major lubricant for joint and tendon surfaces, and is involved in
regulating cell growth.6,7 A study in Prg4/ mice has suggested that
lubricin is needed to prevent protein deposition onto cartilage from
synovial fluid, to inhibit the adhesion of synovial cells to the cartilage
surface and to control adhesion-dependent synovial growth.8 In
addition, the deletion of the gene Prg4 in mice resulted in
significant structural and biomechanical changes in the articular
cartilage with age, some of which are consistent with osteoarthritic
degeneration.9 Lubricin contains multiple domains, in particular the
large central mucin-like domain encoded by exon 6, which is rich of
repeated motifs for post-translationally O-linked glycosylation.10 This
region is thought to be the lubricating domain of lubricin, as the
sequential removal of the last sugars results in loss of boundary
lubricating ability.11
To date, 15 mutations in the PRG4 gene have been reported, which
are associated with CACP syndrome in 20 affected patients mainly of
Arabian origin.4,12–14
In the present study, we report the results of PRG4 gene molecular
analysis in 13 European patients, from 10 unrelated families, who
were diagnosed with CACP syndrome. We identified novel mutations
in the cohort analyzed. Furthermore, we describe a case of CACP
syndrome, resulting from uniparental isodisomy of chromosome 1.
MATERIALS AND METHODS
Patients
A total of 13 patients from 10 unrelated families were clinically diagnosed with
CACP syndrome and analyzed for the presence of sequence mutations in PRG4
gene. Ten patients were Italian, two were Albanian and one was Dutch. Written
informed consent was obtained from the patient’s parents and the study was
approved by the local ethics commitees.
The clinical features of the patients are reported in Table 1. The age-of-onset
of symptoms was at birth or in the first years of life. All patients had
arthropathy and the majority showed camptodactyly, coxa-vara and synovial
hyperplasia, whereas only 30% of patients exhibited pericarditis.
Genomic DNA was isolated from peripheral blood leukocytes using the
QIAamp DNA Blood Mini Kit according to the manifacturer’s instructions
(Qiagen, Hilden, Germany).
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Sequence analysis
The entire coding sequence, including exon–intron junctions, was amplified
using standard PCR conditions, with the exception of a 800 bp region of exon
6 (c.1092-1871) because of its highly repetitive nature. Primer pairs specific for
exons 1, 2, 3, 4 and 7 were taken from elsewhere,4 all other primers used in this
study can be obtained from the authors. PCR products were sequenced using
the BigDye Terminator Cycle Sequencing Kit (Applied Biosystems, Foster City,
CA, USA) on an automated ABI PRISM 3130 Genetic Analyzer (Applied
Biosystems) and compared with reported reference cDNA sequence (GenBank
accession no. NM_005807.3).
Real-time gene-dosage analysis
Real-time quantitative PCR was performed for PRG4 exons 6 and 12 on a 7500
Fast Real-Time Instrument (Applied Biosystems), using SYBR Green as
intercalating fluorescent dye. The GAPDH gene, located on chromosome 12,
was used as internal reference locus.
Lymphocyte DNAs from 10 control subjects were used as reference normal
samples for the optimization of experimental conditions.
The primer sequences (available upon request) were designed using the
Primer 3 software (http://frodo.wi.mit.edu/).15 One microliter of sample DNA
(20ng) was added to the PCR reaction mixture containing 2 SYBR Green
Master Mix, and 200 nmol/l forward and reverse primers in a final volume of
10ml. All analyses were performed in triplicate. The PCR amplification profile
was as follows: initial denaturation at 95 1C for 5min, followed by 40 cycles of
denaturation at 95 1C for 15 s, annealing for 60 s and extension at 72 1C for
15 s. Detection of the fluorescent product was carried out during the annealing
period. Data analysis was performed using the comparative Delta Delta Ct
(DDCt) method.16 The relative gene copy number was calculated by the
expression 2–DDCt.
Microsatellite analysis for UPD
Ten polymorphic short tandem repeat markers covering both short and long
arms of chromosome 1 were analyzed on one patient’s genomic DNA and on
their parents in order to investigate the parental origin of each copy of
chromosome 1. The following microsatellites were explored: D1S199, D1S220
and D1S207 on the short arm, and D1S2344, D1S2635, D1S191, D1S2877,
D1S249, D1S2827 and D1S2833 on the long arm. Forward primers were labeled
with 6-FAM, TETor HEX fluorescent dyes, and PCR products were analyzed on
a automated ABI PRISM 310 Genetic Analyzer (Applied Biosystems). Product
size determination was assessed with GeneScan software (Applied Biosystems).
RESULTS
A total of 13 patients were investigated for the presence of mutations
in the PRG4 gene coding sequence. This analysis revealed the presence
of six mutations in nine patients (Table 2), five of which were novel
mutations (Figure 1). These include a deletion of 5 bp in exon 10
Table 1 Clinical features of all patients
Clinical manifestations Pt 1 Pt 2 Pt 3 Pt 4 Pt 5 Pt 6 Pt 7 Pt 8 Pt 9 Pt 10 Pt 11 Pt 12 Pt 13
Gender Male Male Male Female Female Female Female Male Female Male Male Male Male
Age at onset 3 y At birth At birth 3 y 3 m 6 m At birth At birth At birth 10 y 7 m At birth 5 y 6 m
Age at diagnosis 12 y 8 y 5 y 6 y 5 y 10 y 5 y 3 y at birth 15 y 3 y 6 y 15 y
Parents consanguinity No No No No No No Yes No No No No No No
Camptodactyly
Hands No No No No Yes Yes Yes Yes Yes No Yes Yes Yes
Feet No Yes Yes No Yes Yes No No No No No Yes Yes
Arthropathy
Elbows Yes Yes Yes No No Yes Yes Yes No Yes Yes Yes No
Wrists Yes Yes No No Yes Yes Yes Yes Yes Yes Yes Yes Yes
Hips Yes Yes Yes Yes Yes Yes Yes Yes No Yes No No No
Knees Yes Yes Yes Yes Yes Yes Yes Yes No Yes Yes Yes No
Ankles Yes Yes Yes No Yes Yes Yes Yes No Yes No No Yes
Pericarditis Yes No No No Yes No No Yes No Yes No No No
X-ray
Joint erosions No No No No Yes Yes Yes No Yes Yes No No Yes
Coxa vara Yes Yes Yes No Yes Yes Yes Yes No Yes Yes Yes Yes
Ecography
Joint effusion No Yes Yes Yes Yes Yes Yes Yes No Yes Yes Yes No
Synovial hyperplasia Yes Yes Yes Yes Yes Yes Yes Yes No Yes Yes Yes Yes
Synovial fluid
Viscous NA Yes Yes Yes Yes Yes Yes Yes No Yes Yes Yes Yes
Honey colored NA Yes Yes Yes Yes Yes Yes Yes No Yes Yes Yes Yes
Low cells count NA Yes Yes Yes NA NA Yes Yes No No Yes Yes Yes
Other affected family members — — — — Sister (Pt 6) Sister (Pt 5) — Sister (Pt 9) Brother (Pt 8) — Brother (Pt 12) Brother (Pt 11) —
Abbreviations: m, months; NA, data not available; Pt, patient; y, years..
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(ref. 4) an alteration of the donor splice site region of intron 8, a
nonsense mutation in exon 9 and three small deletions located in the
inner region of exon 6.
The potential pathogenicity of the splice site mutation has been
examined using different programs, including the splice site predic-
tion tool from the Berkeley Drosophila Genome Project web site
(http://www.fruitfly.org/seq_tools/splice.html),17 NetGene2, available
from the Center of Biological Sequence analysis (http://www.cbs.
dtu.dk/services/NetGene2/)18,19 and Alamut Software version 2.2e
(Interactive Biosoftware, Rouen, France). All programs showed a
marked decrease of the score or the absence of the donor splice site
with an eligible value. The alteration of the donor splice site could
lead to the skipping of exon 8, finally resulting in a frameshift of the
protein sequence and in the formation of a stop codon after nine
amino-acid residues. The nonsense mutation and the small deletions
are also predicted to create a stop codon. This could result either in
the expression of a truncated and non functional protein or in the
absence of lubricin synthesis. The latter possibility has been previously
proved for some nonsense/frameshift PRG4 mutations as a
consequence of nonsense-mediated mRNA decay.20 Unfortunately,
due to the unavailability of synovial fluid from the patients, the
structure of the protein could not be investigated.
All of the mutations were present in a homozygous state in the
patients, whereas none of them were observed in 200 control
chromosomes and in 6500 exomes of the Exome Sequencing Project
(Exome Variant Server, NHLBI GO Exome Sequencing Project (ESP),
Seattle, WA, USA; URL: http://evs.gs.washington.edu/EVS/).
In the case of patient 4, amplification and sequencing of PRG4 exon
6 in the parents showed that the father was a heterozygous carrier of
the c.1982-1983delCT mutation, but the mother did not have this
alteration (Figure 2). This could be either due to the presence of a
large deletion encompassing the portion of exon 6 investigated that is
not detectable by conventional PCR-based methods or due to the
occurrence of uniparental disomy in which the proband inherits both
copies of a chromosome from only one parent.
Gene-dosage analysis performed by real-time quantitative PCR was
able to determine the allelic copy number and demonstrated the
absence of large deletions within chromosome 1 of the proband and
the mother.
The subsequent analysis of microsatellite markers spanning the
whole chromosome 1 revealed that the patient is homozygous for each
short tandem repeat tested, and seven informative loci indicated that
both copies of the chromosome were inherited from the father, thus
showing the existence of a paternal uniparental isodisomy (Figure 3).
DISCUSSION
PRG4 mutations has been described in 20 CACP cases of different
ethnicities but mainly among patients of Arabian origin. In the
Table 2 PRG4 gene mutations identified
Patientsa Location Mutation at cDNA level
Deduced mutation at
protein level
1 Exon 6 c.2754_2758delGACAA p.Lys918Asnfs*10
2 Intron 8 c.3636þ3A4G p.Hys1168Phefs*9
3, 11 and 12 Exon 10 c.3894_3898delGGTTA p.Val1299Glufs*5
4 Exon 6 c.1982_1983delCT p.Pro661Argfs*17
5 and 6 Exon 9 c.3648C4A p.Tyr1216*
10 Exon 6 c.2153delA p.Lys718Argfs*194
aThe identification number of the patients is the one stated in Table 1. *indicate a translation
termination codon.
c.3636+3A>G
(p.Hys1168Phefs*9)
c.1982_1983delCT
(p.Pro661Argfs*17)
C
Somatomedin B-like domains Mucine-like domains Hemopexin-like domain
Chondroitin Sulphate attachment site
N
1 2 3 4 5 6 7 8 9 10 11 12
c.3648C>A
(p.Tyr1216*)
c.2153delA
(p.Lys718Argfs*194)
c.2754_2758delGACAA
(p.Lys918Asnfs*10)
Figure 1 Schematic representation of human lubricin. (a) Protein structure with functional domains; (b) gene structure with location of the novel mutations
identified in the present study.
Figure 2 Electropherogram showing the reverse strand sequence of exon 6
of the family of patient 4. (a) Proband sequence harboring the homozygous
deletion c.1982_1983delCT; (b) father sequence harboring the deletion in
heterozygosity; (c) mother sequence, wild type.
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present study, we report the results of the molecular investigation of
PRG4 gene in the largest European cohort, which includes 13 CACP
patients belonging to 10 unrelated families.
The clinical features exhibited by our series of patients reflect the
classical signs of the syndrome and are consistent with those reported
in previous studies, such as arthropathy of large joints in all patients
described, camptodactyly and coxa vara in the majority of them, and
pericarditis reported in only 20% of cases.1,21 In particular, our case
series includes patients that exhibit all major clinical signs (Pt 5 of
Table 1) and patients presenting only arthropathy, without campto-
dactyly pericarditis and coxa vara (Pt 4 of Table 1), confirming the
clinical variability reported so far within and across families. We have
identified six different sequence variants in nine subjects. One of them
has been reported earlier as a heterozygous alteration,4 whereas five
were novel mutations.
Interestingly, three of the new mutations detected were located in
exon 6, which accounts for 67% of the entire coding sequence and
encodes for the large mucin-like domain. These new mutations
increase the number of variations identified in this portion of the
gene, overall 14 out of 20 mutations in PRG4 occur in exon 6. This
finding strengthens the results of in vitro studies, suggesting that exon
6 encodes the major lubricating domain of lubricin.
Like the majority of the variations already reported, all mutations
identified in our patients are nonsense mutations, frameshift deletions
or splicing defects that are predicted to lead to the creation of a
premature termination codon and subsequently to the lack of lubricin
synthesis, suggesting that CACP syndrome is mainly due to the
complete absence of the proteoglycan 4 protein.
Therefore, this study shows that although the alterations identified
are different in terms of type of mutation and localization within the
gene, they share the same predicted effect on protein synthesis, thus
underlying the genetic homogeneity of the syndrome, which is in
contrast with the clinical variability. This observation, together with
the analysis of the different clinical manifestations of our patients and
in particular of two sisters harboring the same mutation (Pt 5 and
Pt 6 of Table 1), do not allow us to describe the presence of a
phenotype–genotype correlation.
Interestingly, we found a patient with a homozygous mutation in
PRG4 gene in which additional investigations revealed complete
paternal isodisomy of chromosome 1. This is the first report of
CACP syndrome caused by uniparental inheritance. It is noteworthy
that in this case, we did not expect a different phenotype, as it might
be predicted when UPD affect other chromosomes, and this is due to
the absence of imprinting effects on chromosome 1 as reported in
other studies.22 The determination of the occurrence of UPD is
important for the parents in regard to the estimation of the
recurrence risk which, in this case, is below the 25% risk for an
autosomal recessive inheritance.
In conclusion, this report brings new insights into CACP syn-
drome. First of all, it represents the molecular investigation of the
largest European cohort of CACP patients and shows the presence of
several distinct novel mutations of PRG4 gene. In particular, it
revealed the absence of a single or few recurrent mutations as
responsible of the phenotype, differently from other monogenic
diseases where often a single mutation is causative of the majority
of cases.23 Our results strengthen previous data obtained in CACP
patients from other countries, and emphasize the existence of private
pathogenic mutations located in different exons. Thus, the analysis of
the entire coding sequence of PRG4 gene is essential for the molecular
diagnosis of CACP syndrome, with a particular attention to the
sequence investigation of exon 6 in which the majority of mutations
occur. However, although PRG4 gene has to be consider the major
gene linked to the onset of CACP syndrome, a clear genotype–
phenotype correlation has not been shown so far. Further molecular
studies on large cohort of CACP patients could be useful to clarify the
clinical variability of the syndrome.
Our results indicate also that, although our patient represents a
unique example of CACP syndrome caused by UPD, it should be
regarded as a mode of inheritance in cases of CACP when the patient
appears homozygous for a mutation found in only one parent.
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